Correlation Between Plandai Biotech and Marizyme

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Plandai Biotech and Marizyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Plandai Biotech and Marizyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Plandai Biotech and Marizyme, you can compare the effects of market volatilities on Plandai Biotech and Marizyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Plandai Biotech with a short position of Marizyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Plandai Biotech and Marizyme.

Diversification Opportunities for Plandai Biotech and Marizyme

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Plandai and Marizyme is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Plandai Biotech and Marizyme in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marizyme and Plandai Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Plandai Biotech are associated (or correlated) with Marizyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marizyme has no effect on the direction of Plandai Biotech i.e., Plandai Biotech and Marizyme go up and down completely randomly.

Pair Corralation between Plandai Biotech and Marizyme

Given the investment horizon of 90 days Plandai Biotech is expected to generate 1.57 times more return on investment than Marizyme. However, Plandai Biotech is 1.57 times more volatile than Marizyme. It trades about 0.19 of its potential returns per unit of risk. Marizyme is currently generating about 0.15 per unit of risk. If you would invest  0.01  in Plandai Biotech on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Plandai Biotech or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Plandai Biotech  vs.  Marizyme

 Performance 
       Timeline  
Plandai Biotech 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Plandai Biotech are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Plandai Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.
Marizyme 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Marizyme are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Marizyme displayed solid returns over the last few months and may actually be approaching a breakup point.

Plandai Biotech and Marizyme Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Plandai Biotech and Marizyme

The main advantage of trading using opposite Plandai Biotech and Marizyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Plandai Biotech position performs unexpectedly, Marizyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marizyme will offset losses from the drop in Marizyme's long position.
The idea behind Plandai Biotech and Marizyme pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing